RAPT Therapeutics (RAPT) – Analyst PT Change
-
Rapt Therapeutics (RAPT) PT Lowered to $13 at JPMorgan
-
UBS Downgrades Rapt Therapeutics (RAPT) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RAPT Stock Lookup